AGAPE ATP CORPORATION Proceeds from (Repayments of) Related Party Debt
AGAPE ATP CORPORATION (ATPC) reported Proceeds from (Repayments of) Related Party Debt of -$3.85 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt · last filed 2023-03-31
- AGAPE ATP CORPORATION proceeds from (repayments of) related party debt for the quarter ending 2021-12-31 was $4.22K, a 36.45% increase year-over-year.
- AGAPE ATP CORPORATION proceeds from (repayments of) related party debt for the quarter ending 2021-09-30 was -$5.64K, a 172.64% decline year-over-year.
- AGAPE ATP CORPORATION proceeds from (repayments of) related party debt for the quarter ending 2020-12-31 was $3.09K.
- AGAPE ATP CORPORATION proceeds from (repayments of) related party debt for the quarter ending 2020-09-30 was $7.77K.
- AGAPE ATP CORPORATION proceeds from (repayments of) related party debt for fiscal 2021 was -$3.85K, a 101.69% decline from fiscal 2020.
- AGAPE ATP CORPORATION proceeds from (repayments of) related party debt for fiscal 2020 was $227.43K.
- AGAPE ATP CORPORATION proceeds from (repayments of) related party debt for fiscal 2019 was -$5.32K.
- AGAPE ATP CORPORATION proceeds from (repayments of) related party debt for fiscal 2018 was $745.00.
| Period end | Proceeds from (Repayments of) Related Party Debt 3 month | Proceeds from (Repayments of) Related Party Debt 6 month | Proceeds from (Repayments of) Related Party Debt 9 month | Proceeds from (Repayments of) Related Party Debt 12 month |
|---|---|---|---|---|
| 2021-12-31 | $4.22K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$1.42K derived: sum of 2 quarters · filed 2023-03-31 | -$3.85K 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$5.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$8.07K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | -$2.43K 10-Q · filed 2022-08-11 | |||
| 2020-12-31 | $3.09K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2022-07-05 | $10.86K derived: sum of 2 quarters · filed 2022-07-05 | $227.43K 10-K/A · filed 2022-07-05 | |
| 2020-09-30 | $7.77K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2022-07-05 | $224.34K 10-Q/A · filed 2022-07-05 | ||
| 2020-06-30 | $216.57K 10-Q · filed 2021-08-13 | |||
| 2019-12-31 | -$5.32K 10-K · filed 2021-03-31 | |||
| 2018-12-31 | -$745.00 10-K · filed 2020-03-27 | |||
| 2018-06-30 | $745.00 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |